How Risperidone and Paliperidone Affect Thinking in Healthy Volunteers
About this title
Read the official source — NCT01284959Researchers compared risperidone, paliperidone ER and placebo, tracking side effects to assess safety in healthy volunteers.
Understand this study
What did researchers investigate?
Researchers compared risperidone, paliperidone ER and placebo, tracking side effects to assess safety in healthy volunteers.
Who was this study for?
Listed age limits: 18 years to 38 years.
- Listed locations
- JeonjuSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 34
- Sponsor
- Chonbuk National University Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- South Korea
- Age range
- From 18 Years to 38 Years
- Official registry ID
- NCT01284959
- Official title
Show the full official title
Different Safety Profile of Risperidone and Paliperidone Extended-release: a Double-blind, Placebo-controlled Trial With Healthy Volunteers
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Jeonju
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers compared risperidone, paliperidone ER and placebo, tracking side effects to assess safety in healthy volunteers.
Who is behind this study?
The study sponsor is Chonbuk National University Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including risperidone, paliperidone ER and placebo.
Who was this study for?
Listed age limits: 18 years to 38 years.
